Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1977-9-22
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
0364-5134
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
1
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
111-9
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:18978-Adenylate Cyclase,
pubmed-meshheading:18978-Animals,
pubmed-meshheading:18978-Disease Models, Animal,
pubmed-meshheading:18978-Dopamine,
pubmed-meshheading:18978-Humans,
pubmed-meshheading:18978-Nerve Endings,
pubmed-meshheading:18978-Neurotransmitter Agents,
pubmed-meshheading:18978-Parkinson Disease,
pubmed-meshheading:18978-Receptors, Dopamine
|
| pubmed:year |
1977
|
| pubmed:articleTitle |
Developments in the pharmacology and therapeutics of parkinsonism.
|
| pubmed:publicationType |
Journal Article,
In Vitro,
Review
|